Select country set
language
Menu Shopping cart 0,00 Search

Grant projects

The BioVendor company participates in research and development projects funded from public sources together with the key partners in science and research in the Czech Republic.


14312
TH04010303: Development of microRNA-based biomarkers for diagnostics of cancer chemoresistance (01/2019 – 12/2021)


14313
FW01010285: Development and application of novel methodology for monitoring the effectiveness of hypolipidemic therapy and for the risk assessment of subsequent atherosclerotic complications (01/2020 – 12/2023)


FW01010052: Development of new laboratory tests for the diagnosis of inflammation, sepsis and cardiovascular diseases based on chemiluminescence analysis on automated platforms (1/2020 – 12/2023)


14314
EG16_084/0008832: APPLICATION in the field of in vitro diagnostics (1/2017 – 1/2020)


CZ.01.1.02/0.0/0.0/16_092/0008633: Research and development in the field of in vitro diagnostics 2017 - 2018


CZ.01.1.02/0.0/0.0/19_297/0019598: Automation in the field of IN VITRO DIAGNOSTICS 2020 - 2022


Automation in the field of IN VITRO diagnostics.
This project is cooperating with the European Union.
The aim of the project is to expand the company's research and development center. Which lies in the acquisition of technology for RnD in the project will lead to an increase in sales and also to increase international competitiveness and strengthen the company's position in the market.
About project in czech

AUTOMATIZACE V OBLASTI IN VITRO DIAGNOSTIKY
je spolufinancován Evropskou unií.
Cílem projektu je rozšíření výzkumně-vývojového centra společnosti, které spočívá v pořízení technologií pro VaV v oblasti imunodiagnostiky. Realizace projektu povede k nárůstu tržeb a exportu společnosti a ke zvýšení mezinárodní konkurenceschopnosti a upevnění pozice společnosti na trhu.
O projektu


14495
TJ02000049: Development and validation of innovative detection systems for quantification of urinary microRNAs in diagnosis of urologic cancers 2019 - 2021